Insider trading

Period: 120 months Stock: RNAC Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

62 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

62 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

62 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

62 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
62 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
62 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

62 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
6 Jan 2026
Brunn Carsten President and CEO
Sold at will
$162.08K 23,766 at 6.82
6.8%
Not planned
6 Jan 2026
Davis Blaine Chief Financial Officer
Sold at will
$72.23K 10,591 at 6.82
8.0%
Not planned
6 Jan 2026
Miljkovic Milos Chief Medical Officer
Sold at will
$24.37K 3,573 at 6.82
5.7%
Not planned
4 Dec 2025
BARABE TIMOTHY C Director
Bought
$205.80K 30,000 at 6.86
123%
Largest buy in 3 yrs
11 Apr 2025
SPRINGER TIMOTHY A Director · indirect
Bought
$391.45K 36,338 at 10.77
5.9%
11 Apr 2025
Bought
$69.07K 6,412 at 10.77
0.1%
10 Apr 2025
SPRINGER TIMOTHY A Director · indirect
Bought 2×
$508.75K 48,595 at 10.47
8.5%
10 Apr 2025
Bought 2×
$89.77K 8,575 at 10.47
0.1%
9 Apr 2025
SPRINGER TIMOTHY A Director · indirect
Bought 2×
$393.95K 41,782 at 9.43
7.9%
9 Apr 2025
Bought 2×
$69.52K 7,373 at 9.43
0.1%
20 Mar 2025
Bought
$855.59K 54,889 at 15.59
0.6%
19 Mar 2025
Bought
$302.96K 20,234 at 14.97
0.2%
18 Mar 2025
Bought
$212.60K 14,740 at 14.42
0.2%
14 Jan 2025
Bought
$72.40K 4,022 at 18.00
0.0%
13 Jan 2025
Bought 2×
$293.96K 16,945 at 17.35
0.2%
6 Jan 2025
Brunn Carsten President and CEO
Sold at will
$146.57K 8,708 at 16.83
4.1%
Not planned
6 Jan 2025
Davis Blaine Chief Financial Officer
Sold at will
$67.80K 4,028 at 16.83
4.1%
Not planned
6 Jan 2025
Kurtoglu Metin Chief Technology Officer
Sold at will
$41.37K 2,458 at 16.83
3.8%
Not planned
6 Jan 2025
Jewell Christopher M Chief Scientific Officer
Sold at will
$21.65K 1,286 at 16.83
2.3%
Not planned
6 Jan 2025
Miljkovic Milos Chief Medical Officer
Sold at will
$15.96K 948 at 16.83
2.6%
Not planned
6 Jan 2025
English Emily Chief Operations Officer
Sold at will
$15.25K 906 at 16.83
2.2%
Not planned
3 Jan 2025
Brunn Carsten President and CEO
Sold at will
$143.19K 8,563 at 16.72
3.9%
Not planned
3 Jan 2025
Davis Blaine Chief Financial Officer
Sold at will
$66.24K 3,961 at 16.72
3.9%
Not planned
3 Jan 2025
Kurtoglu Metin Chief Technology Officer
Sold at will
$40.42K 2,417 at 16.72
3.6%
Not planned
3 Jan 2025
Jewell Christopher M Chief Scientific Officer
Sold at will
$21.14K 1,264 at 16.72
2.3%
Not planned
3 Jan 2025
Miljkovic Milos Chief Medical Officer
Sold at will
$15.58K 932 at 16.72
2.5%
Not planned
3 Jan 2025
English Emily Chief Operations Officer
Sold at will
$14.90K 891 at 16.72
2.1%
Not planned
23 Dec 2024
Bought
$98.44K 5,181 at 19.00
0.1%
20 Dec 2024
Bought
$412.97K 21,800 at 18.94
0.3%
19 Dec 2024
Bought 3×
$453.62K 25,208 at 17.99
0.3%
10 Dec 2024
Kurtoglu Metin Chief Technology Officer
Sold at will
$70.64K 2,901 at 24.35
5.4%
Not planned
9 Dec 2024
Kurtoglu Metin Chief Technology Officer
Sold at will 2×
$274.49K 10,763 at 25.50
17.4%
Not planned
21 Nov 2024
Kurtoglu Metin Chief Technology Officer
Sold at will
$546.56K 32,789 at 16.67
39.1%
Not planned
20 Nov 2024
Kurtoglu Metin Chief Technology Officer
Sold at will 2×
$98.57K 5,700 at 17.29
10.0%
Not planned
19 Nov 2024
Kurtoglu Metin Chief Technology Officer
Sold at will
$3.90K 200 at 19.50
0.4%
Not planned
18 Nov 2024
Bought 2×
$1.06M 58,295 at 18.12
0.7%
18 Nov 2024
Kurtoglu Metin Chief Technology Officer
Sold at will 2×
$632.64K 34,400 at 18.39
40.3%
Not planned
15 Nov 2024
Bought
$4.74M 277,246 at 17.09
3.4%
15 Nov 2024
Kurtoglu Metin Chief Technology Officer
Sold at will
$379.50K 22,068 at 17.20
30.2%
Not planned
15 Nov 2024
Miljkovic Milos Chief Medical Officer
Sold at will
$342.89K 20,000 at 17.14
52.3%
Sold half or more
15 Nov 2024
Jewell Christopher M Chief Scientific Officer
Sold at will
$274.09K 16,065 at 17.06
38.2%
Not planned
14 Nov 2024
Bought 2×
$1.58M 96,399 at 16.37
1.2%
14 Nov 2024
Jewell Christopher M Chief Scientific Officer
Sold at will 2×
$600.95K 36,050 at 16.67
58.2%
Sold half or more
14 Nov 2024
Miljkovic Milos Chief Medical Officer
Sold at will
$564.64K 35,000 at 16.13
65.7%
Sold half or more
14 Nov 2024
Kurtoglu Metin Chief Technology Officer
Sold at will 2×
$425.90K 25,900 at 16.44
33.7%
Not planned
4 Oct 2024
Bought 4×
$1.81M 80,301 at 22.58
1.0%
3 Oct 2024
Bought 5×
$2.38M 119,906 at 19.89
1.5%
2 Oct 2024
Bought
$95.82K 5,514 at 17.38
0.1%
12 Aug 2024
SPRINGER TIMOTHY A Director · indirect
Bought
$101.97K 8,016 at 12.72
229%
+229% of stake
12 Aug 2024
BARABE TIMOTHY C Director
Bought
$95.25K 7,500 at 12.70
52.6%
Largest buy in 3 yrs
Showing 1–50 of 62. Page 1 of 2 Older →